Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia

Jihong Ma, Zhaohui Wang, Danielle Mintzlaff, Huiping Zhang, Rashmi Ramakrishna, Eduardo Davila, Matthew T. Witkowski, M Scott Lucia, Marc S. Schwartz, Elizabeth A. Pomfret, David W. Mathes, Zhirui Wang

Blood blood.2024025277.

https://doi.org/10.1182/blood.2024025277

Published: 2024

Includes: Supplemental data

Journal Articles

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations

Damon E. Houghton, David M Scott, Waldemar E. Wysokinski, Rajiv K. Pruthi, Meera Sridharan, Leslie Padrnos, Surbhi Shah, Aneel A. Ashrani, Anand Padmanabhan, Ewa Wysokinska, Robert D. McBane, Lisa Baumann Kreuziger

Blood (2022) 140 (Supplement 1): 8545–8547.

https://doi.org/10.1182/blood-2022-168142

Published: 2022

Journal Articles

Validation of Natural Language Processing for the Identification of Venous Thromboembolism in Radiologic Reports

David M Scott, Damon E. Houghton, Lisa Baumann Kreuziger

Blood (2022) 140 (Supplement 1): 2794.

https://doi.org/10.1182/blood-2022-163708

Published: 2022

Journal Articles

Rapid Immune Reconstitution and Elevated Regulatory T Cell Frequencies in Patients Treated with Orca-T

Everett H Meyer, M Scott Killian, Anna Pavlova, Cameron Bader, Sean Summers, Fernando Teque, J Scott McClellan, Nathaniel B Fernhoff

Blood (2022) 140 (Supplement 1): 7656–7657.

https://doi.org/10.1182/blood-2022-164468

Published: 2022

Journal Articles

Beliefs, Goals, Preferences, and Top Concerns of Patients with Acute Myeloid Leukemia at a Treatment Decision Visit

Omer H Jamy, Debra M Wujcik, William Dudley, Julie M Scott, Leah Dudley

Blood (2022) 140 (Supplement 1): 7952–7953.

https://doi.org/10.1182/blood-2022-167609

Published: 2022

Journal Articles

Managing Multiple Myeloma in Older Adults Using Real World Evidence and Clinical Integration of a Geriatric Assessment Tool in Clinical Practice

Smith Giri, D'Ambra Dent, Kelly N. Godby, Luciano J. Costa, Susan Bal, Gayathri Ravi, Stacey Ingram, William Dudley, Matthew Dudley, Julie M Scott, Debra M Wujcik

Blood (2021) 138 (Supplement 1): 5019.

https://doi.org/10.1182/blood-2021-153753

Published: 2021

Journal Articles

Integrating Touchscreen-Based Geriatric Assessment and Frailty Screening for Adults with Acute Myelogenous Leukemia to Drive Personalized Treatment Decisions

Omer Hassan Jamy, Stacey Ingram, D'Ambra Dent, William Dudley, Matthew Dudley, Julie M Scott, Debra M Wujcik

Blood (2021) 138 (Supplement 1): 4050.

https://doi.org/10.1182/blood-2021-148806

Published: 2021

Journal Articles

Avenue - Avelumab in the Frontline Treatment of Advanced Classic Hodgkin Lymphoma - a Window Study

Stephen Booth, Eliza Hawkes, Amy A Kirkwood, Sally F Barrington, Patrick G. Medd, Pamela McKay, Ruth Pettengell, Sunil Iyengar, Fiona Miall, John Radford, Cathy Burton, Amit Sud, Nimish Shah, Andrew M Scott, Arzhang Ardavan, Michael Northend, Laura Clifton-Hadley, Richard Jenner, Graham P. Collins

Blood (2021) 138 (Supplement 1): 2470.

https://doi.org/10.1182/blood-2021-145189

Published: 2021

Journal Articles

Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study

Eliza A Hawkes, FRACP,MDMBBS, Geoffrey Chong, MD, Charmaine Smith, Sze-Ting Lee, Leonid Churilov, Joseph McKendrick, William Renwick, Piers Blombery, MBBS, Niles Elizabeth Nelson, BSc, MBBS, Tineke Fancourt, Joanne Hawking, Wendi Lin, Andrew M Scott, Allison Barraclough, Joel Wight, Andrew Grigg, MBBS, MD FRACP, FRCPA, Colm Keane, MD, Chun Yew Fong, MBBS, PhD FRACP, FRCPA, Kate Manos, MBBS

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-136024

Published: 2020

Journal Articles

The Prevalence of Mood and Alcohol Related Disorders within the Adult Sickle Cell Disease Population and Their Impact on Healthcare Utilization

Sonya J. Bruton, MA, MPA, Mehdi Nouraie, MD PhD, Denise M. Scott, MS, PhD, Thomas Gilmore, PhD, Robert E. Taylor, MD PhD

Blood (2015) 126 (23): 2063.

https://doi.org/10.1182/blood.V126.23.2063.2063

Published: 2015

Journal Articles

Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research

Ting Zhou, Marsha C. Kinney, Linda M. Scott, Sandra S. Zinkel, Vivienne I. Rebel

Blood (2015) 126 (9): 1057–1068.

https://doi.org/10.1182/blood-2015-01-624239

Published: 2015

Journal Articles

Immunotherapeutic Targeting of EphA3

Sara Charmsaz, Kirrilee J Miller, Bryan W Day, PhD, Fares El-Ajeh, PhD, Varghese Palath, PhD, Geoff T Yarranton, PhD, Christopher R Bebbington, DPhil., Andrew M Scott, PhD, Martin Lackmann, PhD, Andrew W Boyd, MD PhD

Blood (2014) 124 (21): 3720.

https://doi.org/10.1182/blood.V124.21.3720.3720

Published: 2014

Journal Articles

EphA3 As a Target For Monoclonal Antibody Therapy For Acute Leukemia

Sara Charmsaz, Kirrilee J Miller, Bryan W Day, PhD, Fares El-Ajeh, PhD, Geoff T Yarranton, PhD, Christopher R Bebbington, DPhil., Andrew M Scott, PhD, Martin Lackmann, PhD, Andrew W Boyd, MD, PhD

Blood (2013) 122 (21): 5013.

https://doi.org/10.1182/blood.V122.21.5013.5013

Published: 2013

Journal Articles

Treatment Patterns and Associated Outcomes in Chronic Phase CML Patients Who Fail Imatinib 400 Mg Daily

Jessica M. Scott, BS, Michael J. Mauro, MD

Blood (2011) 118 (21): 4436.

https://doi.org/10.1182/blood.V118.21.4436.4436

Published: 2011

Journal Articles

JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemia

Juan Li, Dominik Spensberger, Jong Sook Ahn, Shubha Anand, Philip A. Beer, Cedric Ghevaert, Edwin Chen, Ariel Forrai, Linda M. Scott, Rita Ferreira, Peter J. Campbell, Steve P. Watson, Pentao Liu, Wendy N. Erber, Brian J. P. Huntly, Katrin Ottersbach, Anthony R. Green

Blood (2010) 116 (9): 1528–1538.

https://doi.org/10.1182/blood-2009-12-259747

Published: 2010

Includes: Supplemental data

Journal Articles

The JAK2 46/1 haplotype predisposes to MPL -mutated myeloproliferative neoplasms

Amy V. Jones, Peter J. Campbell, Philip A. Beer, Susanne Schnittger, Alessandro M. Vannucchi, Katerina Zoi, Melanie J. Percy, Mary Frances McMullin, Linda M. Scott, William Tapper, Richard T. Silver, David Oscier, Claire N. Harrison, Harald Grallert, Aliaksei Kisialiou, Paul Strike, Andrew J. Chase, Anthony R. Green, Nicholas C. P. Cross

Blood (2010) 115 (22): 4517–4523.

https://doi.org/10.1182/blood-2009-08-236448

Published: 2010

Includes: Supplemental data

Journal Articles

A Recombinant Human Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Shows Selective Cytotoxicity against Myeloid Leukemia Cells and CD123-Positive Leukemic Stem Cells.

Varghese Palath, PhD, Rohini Vekhande, Andreia Lee, Jason Williams, Ling Zhang, MD, Alan F List, MD, Andrew Boyd, MD, PhD, Martin Lackmann, PhD, Andrew M Scott, PhD, Daniela Cilloni, MD, PhD, Geoffrey T. Yarranton, PhD, Christopher Bebbington, DPhil

Blood (2009) 114 (22): 1728.

https://doi.org/10.1182/blood.V114.22.1728.1728

Published: 2009

Journal Articles

Targeting Hsp70 in Multiple Myeloma Induces Synergistic Cytotoxicity with Inhibitors of the Proteasome and of Hsp90

Marc J Braunstein, Craig M Scott, Shannon Behrman, Peter Walter, PhD, Peter Wipf, PhD, Eric LP Smith, PhD, Sadeaqua S Scott, BA, H. Uwe Klueppelberg, MD, Jeffrey L Brodsky, PhD, Olcay Batuman, MD

Blood (2008) 112 (11): 5160.

https://doi.org/10.1182/blood.V112.11.5160.5160

Published: 2008

Journal Articles

Targeting Lewis Y-Positive Multiple Myeloma and Acute Myeloid Leukemia with Gene-Modified T Cells Demonstrating Memory Phenotype

Stefan Peinert, David S. Ritchie, Dirk Hoenemann, Simon J. Harrison, Preethi Guru, Michael H. Kershaw, Amanda Shin, Mark J. Smyth, Joseph A. Trapani, Andrew M Scott, Glenn A Cartwright, Fiona E Smyth, Barbara E Power, Phillip K. Darcy, Peter Gambell, David Westerman, Paul Neeson, H. Miles Prince

Blood (2008) 112 (11): 3900.

https://doi.org/10.1182/blood.V112.11.3900.3900

Published: 2008

Journal Articles

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip A. Beer, Peter J. Campbell, Linda M. Scott, Anthony J. Bench, Wendy N. Erber, David Bareford, Bridget S. Wilkins, John T. Reilly, Hans C. Hasselbalch, Richard Bowman, Keith Wheatley, Georgina Buck, Claire N. Harrison, Anthony R. Green

Blood (2008) 112 (1): 141–149.

https://doi.org/10.1182/blood-2008-01-131664

Published: 2008

Includes: Supplemental data

NARROW

Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations

Validation of Natural Language Processing for the Identification of Venous Thromboembolism in Radiologic Reports

Rapid Immune Reconstitution and Elevated Regulatory T Cell Frequencies in Patients Treated with Orca-T

Beliefs, Goals, Preferences, and Top Concerns of Patients with Acute Myeloid Leukemia at a Treatment Decision Visit

Managing Multiple Myeloma in Older Adults Using Real World Evidence and Clinical Integration of a Geriatric Assessment Tool in Clinical Practice

Integrating Touchscreen-Based Geriatric Assessment and Frailty Screening for Adults with Acute Myelogenous Leukemia to Drive Personalized Treatment Decisions

Avenue - Avelumab in the Frontline Treatment of Advanced Classic Hodgkin Lymphoma - a Window Study

Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study

The Prevalence of Mood and Alcohol Related Disorders within the Adult Sickle Cell Disease Population and Their Impact on Healthcare Utilization

Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research

Immunotherapeutic Targeting of EphA3

EphA3 As a Target For Monoclonal Antibody Therapy For Acute Leukemia

Treatment Patterns and Associated Outcomes in Chronic Phase CML Patients Who Fail Imatinib 400 Mg Daily

JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemia

The JAK2 46/1 haplotype predisposes to MPL -mutated myeloproliferative neoplasms

A Recombinant Human Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Shows Selective Cytotoxicity against Myeloid Leukemia Cells and CD123-Positive Leukemic Stem Cells.

Targeting Hsp70 in Multiple Myeloma Induces Synergistic Cytotoxicity with Inhibitors of the Proteasome and of Hsp90

Targeting Lewis Y-Positive Multiple Myeloma and Acute Myeloid Leukemia with Gene-Modified T Cells Demonstrating Memory Phenotype

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only